Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Connecticut Biotech is a private Connecticut-based healthcare products company founded in 2020 during the COVID-19 pandemic to develop safer and more comfortable personal protective equipment. Its principal product is the Secure Fit Mask Frame, a custom 3D-printed exoskeletal frame designed to improve the fit and seal of conventional surgical or procedure masks. The company also markets other PPE products, including N95 respirators, surgical masks, gloves, gowns, and related supplies. Connecticut Biotech was developed in collaboration with researchers associated with the University of Connecticut and built production capabilities in South Windsor, Connecticut. The business appears to operate primarily as a commercial-stage PPE product company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Connecticut Biotech.